Voniza™

Vonoprazan
Potassium Competitive Acid Blockers (PCAB) (Antiulcerant)

Indication:

• Gastric ulcer (GU)
• Duodenal ulcer (DU)
• Reflux esophagitis (RE) and (erosive esophagitis EE)
• Maintenance treatment of reflux esophagitis (erosive esophagitis) in patients with repeat recurrence and relapse of the condition
• Prevention of recurrence of gastric ulcer or duodenal ulcer during NSAIDs administration
• Adjunct to Helicobacter pylori eradication associated with: Gastric ulcer, duodenal ulcer, gastric MALT lymphoma, idiopathic thrombocytopenic purpura, the stomach after endoscopic resection of early stage cancer, or Helicobacter pylori gastritis

Dosage & Administration:

Indication	Dose	Frequency
Gastric ulcer	20 mg	Once daily for 8 weeks
Duodenal ulcer	20 mg	Once daily for 6 weeks
Reflux esophagitis (erosive esophagitis):	20 mg	Once daily for 4 weeks
Prevention of recurrence of gastric ulcer or duodenal ulcer during NSAIDs administration	10 mg	Once a day

Preparation:

Voniza^TM 10: Each box contains 30 tablets in a blister pack.
Voniza^TM 20: Each box contains 30 tablets in a blister pack.